庞
庞正伟 Directeur exécutif
Other
Explore the full record of transactions filed by 庞正伟, Directeur exécutif. Officer active across 1 company, notably 同和药业. Aggregated, 13 disclosures have been recorded. Regulator: SSE / SZSE (CSRC). The full history is openly available.
Declarations 13 total
● 董事,高管 · Executives · 9 Dec 2021 · 同和药业 723,800 shares A股 SZSE:173000005346049100 Ideal exit: 5 Sept 2022 (T+270) ● 董事,高管 · Executives · 8 Dec 2021 · 同和药业 341,900 shares A股 SZSE:173000005150958140 Ideal exit: 4 Sept 2022 (T+270) ● 董事,高管 · Executives · 7 Dec 2021 · 同和药业 87,600 shares A股 SZSE:173000005146928030 Ideal exit: 3 Sept 2022 (T+270) ● 董事,高管 · Executives · 7 Dec 2021 · 同和药业 118,000 shares A股 SZSE:173000005146847070 Ideal exit: 3 Sept 2022 (T+270) ● 董事,总裁 · Executives · 6 Dec 2021 · 同和药业 240,320 shares A股 SZSE:173000005142443650 Ideal exit: 2 Sept 2022 (T+270) ● 董事 · Executives · 2 Dec 2021 · 同和药业 360,000 shares A股 SZSE:173000005130234340 Ideal exit: 29 Aug 2022 (T+270) ● 董事,高管 · Executives · 3 Nov 2021 · 同和药业 39,500 shares A股 SZSE:173000005038892640 Ideal exit: 31 Jul 2022 (T+270) ● 董事 · Executives · 24 Sept 2021 · 同和药业 423,600 shares A股 SZSE:173000005129698200 Ideal exit: 21 Jun 2022 (T+270) ● 董事,高管 · Executives · 23 Sept 2021 · 同和药业 50,000 shares A股 SZSE:173000004905057730 Ideal exit: 20 Jun 2022 (T+270) ● 董事,高管 · Executives · 10 Sept 2021 · 同和药业 300,000 shares A股 SZSE:173000004818779360 Ideal exit: 7 Jun 2022 (T+270) ● 董事,高管 · Executives · 9 Sept 2021 · 同和药业 200,000 shares A股 SZSE:173000004799263680 Ideal exit: 6 Jun 2022 (T+270) ● 董事,高管 · Executives · 26 May 2021 · 同和药业 300,000 shares A股 SZSE:173000004441833100 Ideal exit: 20 Feb 2022 (T+270) ● 董事,高管 · Executives · 24 May 2021 · 同和药业 949,400 shares A股 SZSE:173000004436315800 Ideal exit: 18 Feb 2022 (T+270) About 庞正伟 Pang Zhengwei is an Executive Director and Board Member at Tonghe Pharmaceutical. He plays a key role in managing operations and strategic decision-making, contributing to the company's growth and sustainability.